Hyperbaric Oxygen Therapy for Wound Healing

Pressure, oxygen and the wound that will not close

Some wounds follow a predictable path: inflammation, new tissue, closure. Others stall. The tissue stays hypoxic, bacteria persist, and the usual treatments move the situation only partially. Hyperbaric oxygen therapy for wound healing entered clinical practice precisely for these situations, not as a general wellness tool but as a specific intervention for a specific physiological problem.

The mechanism is straightforward. Breathing pure oxygen at above-normal atmospheric pressure raises the amount of dissolved oxygen in plasma, which carries it to tissue where red blood cells may not be reaching efficiently. That oxygen supports collagen synthesis, stimulates new blood vessel formation, and reduces certain bacterial activity. The effect is local, transient after each session, and cumulative across a series.

What that means clinically is that the therapy is not interchangeable with other treatments. It is an adjunct, not a replacement for surgical debridement, offloading a diabetic foot, or treating the underlying vascular disease. When it is used without addressing those factors, the results are limited regardless of how many sessions are completed.

Hyperbaric oxygen therapy benefits: what the evidence actually supports

The clearest clinical support for hyperbaric oxygen therapy benefits in wound care sits in a specific set of indications. These are conditions where tissue hypoxia is a documented driver of the problem, not just a secondary feature.

Diabetic foot ulcers with poor local perfusion represent the most studied indication. In these cases, the wound is not failing because debridement was inadequate; it is failing because the tissue cannot sustain the repair process without an external oxygen source. Hyperbaric therapy addresses that gap directly.

Radiation-induced tissue injury is another accepted indication. Tissue that has been damaged by therapeutic radiation loses its vascular architecture over time. This process can manifest years after the original treatment and produces wounds that are structurally unable to heal through conventional care alone. Hyperbaric oxygen supports re-vascularization in this context.

Necrotizing soft tissue infections, where hyperbaric oxygen is used alongside surgery and antibiotics, represent a third area with clinical support. The rationale is bacterial: certain anaerobic organisms are sensitive to elevated oxygen tension, so raising that tension in the wound environment can support the antimicrobial effort.

The therapy addresses a physiological gap. When the gap is real and documented, the intervention has a rational basis. When it is not, the rationale disappears.

Chronic non-healing wounds that do not fit neatly into these categories require more individual judgment. The key clinical question is always whether tissue hypoxia is a primary driver in that specific wound, in that specific patient, and whether the other factors maintaining the wound have been addressed.

What is still under study

The evidence for several other conditions is active but not settled. This matters practically because it affects how a protocol is justified and how a patient should understand what they are agreeing to.

Traumatic brain injury, stroke recovery, and certain neurological conditions have attracted considerable research interest. The proposed mechanism, that increasing systemic oxygen delivery can support tissue in the penumbra around a primary injury, is biologically plausible. The clinical evidence, however, has not yet produced consistent enough results to move these indications from investigational to standard of care.

Autoimmune conditions involving tissue ischemia, Crohn's-related perianal disease, and certain refractory osteomyelitis cases are also subjects of ongoing study. For some of these, early results are interesting. For others, the populations studied have been too small or too heterogeneous to draw conclusions that generalize.

Long COVID symptom clusters, including fatigue and cognitive complaints, have been studied in small protocols. The results have been mixed, and the mechanism remains unclear. This is an area where clinical enthusiasm has, in several cases, moved ahead of the evidence.

Where hyperbaric oxygen therapy for wound healing does not apply

Knowing where the therapy does not apply is as clinically important as knowing where it does. Not every chronic wound is a hyperbaric indication, and applying it outside its rational basis does not improve outcomes; it adds sessions, cost, and time without addressing the actual problem.

Wounds that are failing because of persistent infection that has not been surgically managed, because of mechanical pressure that has not been offloaded, or because of nutritional deficiencies are not primarily hypoxic problems. Addressing only the oxygen component while leaving those factors in place is not a complete treatment plan.

Arterial insufficiency wounds require revascularization as the primary intervention. Hyperbaric oxygen can support healing in tissue with moderate ischemia, but it cannot substitute for restoring blood flow in severe arterial disease. The assessment has to determine which situation applies before a protocol begins.

Contraindications are also real. Certain pulmonary conditions, untreated pneumothorax, and some medications interact with hyperbaric conditions in ways that make the therapy inappropriate or require modification of the approach. A thorough clinical assessment is not procedural courtesy; it is what makes the protocol safe.

The assessment does not exist to confirm a decision already made. It exists to determine whether a decision is rational in the first place.

flowchart TD
    A["Chronic or non-healing wound"] --> B["Is tissue hypoxia a primary driver?"]
    B -->|"Yes, documented"| C["Review contraindications"]
    B -->|"Unclear or no"| D["Address underlying cause first"]
    C -->|"None present"| E["Hyperbaric protocol as adjunct"]
    C -->|"Contraindication found"| F["Modify approach or defer"]
    E --> G["Structured follow-up and reassessment"]
    D --> H["Reassess for hyperbaric candidacy"]

How a hyperbaric oxygen protocol is built and measured

A hyperbaric oxygen protocol for wound healing is not a fixed number of sessions applied to a diagnosis. It is a structure built around the individual wound, the patient's overall condition, and measurable response over time.

In general, a session involves breathing pure oxygen inside a pressurized chamber for a defined period. The number of sessions in a series depends on the indication, the wound's response at interim reassessment points, and the patient's tolerance. A wound that is responding may follow one path; a wound that plateaus may require a different approach or a reassessment of whether hyperbaric therapy is the right adjunct for that case.

Measurement matters throughout. Wound size, tissue quality, perfusion markers, and systemic factors all contribute to determining whether the protocol is producing the expected effect. A plan that does not include interim assessment points is not a supervised protocol; it is a series of sessions without a clinical framework.

For patients traveling from the United States or Canada, the continuity question is practical. A protocol that begins in Cancún and ends at the last session before a flight home is incomplete. Medical supervision during the series, a written plan, and structured follow-up after the patient returns home are part of the same clinical commitment, not optional additions.

Hyperbaric oxygen therapy benefits in context: what this means for a patient evaluating care abroad

If you are considering hyperbaric oxygen therapy benefits as part of a care plan and you are evaluating options in Cancún, the first question to ask is not about the chamber. It is about the assessment process and what happens after.

At Longevia Medical, located in Puerto Cancún, care starts with an assessment, in person or remote. The assessment determines whether a hyperbaric protocol is indicated for your specific situation, what the protocol would include, and how progress would be measured. The plan is individual and given in writing. Follow-up continues after you return home.

The clinical team includes Dr. María Guadalupe Navarro Barrientos, Physician, Surgeon and Homeopath (IPN); Molecular Biomedicine (IPN); Medical Research, IPN School of Medicine. Her academic work is in hyperbaric oxygenation and oxidative biomarkers, which is exactly the measurement framework that a serious wound-healing protocol requires.

What we cannot tell you here is whether hyperbaric oxygen therapy applies to your wound. That determination belongs in the assessment, not in an article. What we can say is that the indications are specific, the contraindications are real, and the protocol requires structure. If those conditions are present, the conversation is worth having.

A protocol that cannot explain its own endpoint is not a protocol. It is a service sold by the session.

Symptoms that require emergency care, not a clinic message

This section exists because wound care patients are often managing complex systemic conditions alongside their wound. If you experience sudden trouble breathing, chest pain, new neurological symptoms such as weakness or confusion, or a wound that rapidly turns white, dusky, or develops severe escalating pain, those are emergency symptoms. Go to an emergency room immediately. Do not send a message to a clinic or wait for a callback.

Hyperbaric therapy is a planned, supervised intervention. It is not a response to acute deterioration, and no element of a hyperbaric protocol substitutes for emergency medical care when emergency medical care is what the situation requires.

Frequently Asked Questions

What does hyperbaric oxygen therapy for wound healing actually do?

It raises the amount of dissolved oxygen in plasma, delivering it to tissue where circulation is insufficient. This supports collagen synthesis, stimulates new vessel formation, and reduces activity of certain bacteria. It works as an adjunct to other wound care, not as a standalone treatment.

Which wound types are accepted indications for hyperbaric oxygen therapy?

Diabetic foot ulcers with documented poor perfusion, radiation-induced tissue injury, and necrotizing soft tissue infections used alongside surgery and antibiotics are the best-supported indications. Candidacy depends on an individual assessment, not on the diagnosis alone.

Can hyperbaric oxygen therapy replace surgery or revascularization?

No. It is an adjunct therapy. Wounds failing because of unaddressed arterial insufficiency, uncontrolled infection, or mechanical pressure require those problems to be treated directly. Hyperbaric oxygen supports healing once the primary barriers have been managed.

How is progress measured during a hyperbaric oxygen protocol?

Wound size, tissue quality, perfusion indicators, and systemic factors are assessed at defined points during the protocol. A supervised series includes interim reassessment; if the wound is not responding as expected, the plan is reviewed before the series continues.

Can I start a hyperbaric protocol in Cancún and continue care when I return home?

Medical supervision and structured follow-up after returning home are part of a complete protocol. An assessment, a written individual plan, and continuation of care after the in-person phase are how a protocol maintains clinical continuity across distance.

For patients who want to read further on wound healing and oxygen therapy from independent sources, Mayo Clinic and MedlinePlus both publish accessible patient-oriented information on hyperbaric oxygen therapy and chronic wound management.